Efficacy of Omalizumab in Indolent Systemic Mastocytosis

Case Reports in Hematology
doi 10.1155/2019/3787586
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Hindawi Limited

Related search

Delayed Diagnosis of Adult Indolent Systemic Mastocytosis

Dermatology Reports
Dermatology
2014English

Endoscopic Findings of Indolent Systemic Mastocytosis Involving the Colon

Endoscopy
Gastroenterology
2014English

Fragility Fractures as the Initial Manifestation of Indolent Systemic Mastocytosis

Endocrine Abstracts
2015English

Omalizumab and Systemic Mastocytosis: A Single Centre Case Series

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

Smouldering Mastocytosis: Survival Comparisons With Indolent and Aggressive Mastocytosis

American Journal of Hematology
Hematology
2018English

The Efficacy of Cladribine (2-CdA) in Advanced Systemic Mastocytosis

Indian Journal of Hematology and Blood Transfusion
Hematology
2020English

Systemic Mastocytosis

2020English

Masitinib for Treatment of Severely Symptomatic Indolent Systemic Mastocytosis: A Randomised, Placebo-Controlled, Phase 3 Study

The Lancet
Medicine
2017English

Masitinib for Treatment of Severely Symptomatic Indolent Systemic Mastocytosis: A Randomised, Placebo-Controlled, Phase 3 Study

2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy